Live feed
Filing
SC 13G/A
SC 13G/A0001104659-16-107946·OncoMed Pharmaceuticals Inc
Schedule 13G ownership disclosure
ONCOMED PHARMACEUTICALS INC
Security class unavailable · CUSIP: 68234X102
Event date: 2016-03-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,421,740
- Percent of class
- 4.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-107946
- Form type
- SC 13G/A
- Filer
- OncoMed Pharmaceuticals Inc
- CIK
- CIK 1302573
- Filed
- Mar 28, 2016
- Reporting period
- Mar 17, 2016
- Description
- Schedule 13G beneficial ownership